Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
179,252,507
-
Total 13F shares
-
88,017
-
Share change
-
-13,694
-
Total reported value
-
$117,891
-
Price per share
-
$1.34
-
Number of holders
-
12
-
Value change
-
-$18,399
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q3 2023
As of 30 Sep 2023,
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,017 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, BlackRock Inc., UBS Group AG, Tower Research Capital LLC (TRC), CITIGROUP INC, OSAIC HOLDINGS, INC., and WELLS FARGO & COMPANY/MN.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.